Clinical Trial Update: Evaluation of Efficacy and Safety of AVE5530 Co-administered With Atorvastatin in Primary Hypercholesterolemia [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating AVE5530 co-administered with atorvastatin for primary hypercholesterolemia was terminated; the update discusses efficacy and safety a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• AVE5530
• atorvastatin (atorvastatin)

Snippet

Sponsor: Sanofi | Conditions: Hypercholesterolemia | Phase 3 | Status: TERMINATED